NuVasive Reports 3Q18 Revenue of $271.3MM, +9.6% vs. 3Q17

NuVasive leveraged favorable market conditions and new product launches to post 3Q18 revenue of $271.3MM, +9.8% vs. 3Q17. The company believes that its transformation from a mechanical and implant-based portfolio to a systems-based player will enable them to take market share.

Favorable Market Conditions Spur Accelerated Case...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0